Dr. Prendergast is an Alpha Omega Alpha graduate of the University of Florida College of Medicine, where he graduated with Honors in Research. He completed a medical internship at the Colorado Health Foundation in Denver, CO, followed by a residency in Radiation Oncology at the University of Alabama Birmingham (UAB). While at UAB, Dr. Prendergast completed the Clinical and Translational Science Training Program and published ten manuscripts in peer-reviewed scientific journals. He is a board-certified diplomate of The American Board of Radiology.
Since 2013, Dr. Prendergast has been in community practice on Florida's Space Coast. He currently holds an adjunct faculty appointment at the University of Central Florida College of Medicine and represents radiation oncology on the board of the Florida Society for Clinical Oncology.
In his clinical practice, Dr. Prendergast frequently administers radiopharmaceuticals for a variety of malignancies. As an active user of alpha-emitting radionuclides, Dr. Prendergast is uniquely familiar with both the clinical and radiation safety issues of targeted alpha particle therapy.